US Bancorp DE Has $5 Million Stock Position in Cardinal Health, Inc. (NYSE:CAH)

US Bancorp DE decreased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 2.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 45,258 shares of the company’s stock after selling 961 shares during the period. US Bancorp DE’s holdings in Cardinal Health were worth $5,002,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of CAH. Eastern Bank bought a new position in shares of Cardinal Health during the third quarter valued at about $25,000. Cultivar Capital Inc. purchased a new stake in shares of Cardinal Health in the 2nd quarter worth about $27,000. Ashton Thomas Private Wealth LLC purchased a new stake in shares of Cardinal Health in the 2nd quarter worth about $29,000. LRI Investments LLC purchased a new stake in Cardinal Health during the 1st quarter valued at about $32,000. Finally, New Covenant Trust Company N.A. purchased a new stake in shares of Cardinal Health during the 1st quarter valued at about $40,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 17,896 shares of the firm’s stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total value of $1,905,566.08. Following the completion of the transaction, the insider now directly owns 94,529 shares of the company’s stock, valued at $10,065,447.92. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Cardinal Health news, insider Jessica L. Mayer sold 17,896 shares of Cardinal Health stock in a transaction dated Thursday, August 15th. The shares were sold at an average price of $106.48, for a total value of $1,905,566.08. Following the completion of the transaction, the insider now directly owns 94,529 shares of the company’s stock, valued at approximately $10,065,447.92. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Michelle D. Greene sold 4,000 shares of the company’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $108.85, for a total transaction of $435,400.00. Following the transaction, the insider now owns 19,242 shares of the company’s stock, valued at approximately $2,094,491.70. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 113,963 shares of company stock valued at $12,379,980 in the last 90 days. 0.09% of the stock is currently owned by corporate insiders.

Cardinal Health Price Performance

Shares of Cardinal Health stock opened at $111.90 on Tuesday. The company has a market capitalization of $27.08 billion, a P/E ratio of 21.77, a PEG ratio of 1.49 and a beta of 0.60. The business’s fifty day moving average price is $111.75 and its two-hundred day moving average price is $104.15. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $119.13.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.64 by $0.24. Cardinal Health had a negative return on equity of 54.85% and a net margin of 0.37%. The business had revenue of $52.28 billion for the quarter, compared to analyst estimates of $50.90 billion. During the same period in the previous year, the company posted $1.73 earnings per share. The firm’s revenue for the quarter was down 4.3% on a year-over-year basis. On average, research analysts expect that Cardinal Health, Inc. will post 7.61 earnings per share for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st were issued a $0.506 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date was Tuesday, October 1st. This represents a $2.02 annualized dividend and a yield of 1.81%. Cardinal Health’s payout ratio is presently 39.30%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the stock. JPMorgan Chase & Co. raised their target price on shares of Cardinal Health from $111.00 to $123.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 21st. Argus lifted their price objective on Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a report on Wednesday, September 11th. UBS Group boosted their target price on shares of Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a report on Monday. Morgan Stanley boosted their target price on shares of Cardinal Health from $119.00 to $127.00 and gave the stock an “overweight” rating in a report on Monday. Finally, Robert W. Baird boosted their price target on Cardinal Health from $130.00 to $137.00 and gave the stock an “outperform” rating in a research note on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and eight have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $123.00.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.